Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
A 10-year follow-up of the European multicenter trial of interferon β-1b in secondary-progressive multiple sclerosis.
A randomized controlled phase II trial of riluzole in early multiple sclerosis.
The search for the target antigens of multiple sclerosis, part 2: CD8+ T cells, B cells, and antibodies in the focus of reverse-translational research.
Treatment satisfaction in multiple sclerosis.
Dimethyl fumarate treatment alters circulating T helper cell subsets in multiple sclerosis.
Multiple sclerosis in pregnancy.
Interferon beta-1b-induced Sweet's syndrome in a patient with multiple sclerosis.
Gpr126 functions in Schwann cells to control differentiation and myelination via G-protein activation.
Spectrum of nontraumatic myelopathies in Ethiopian patients: hospital-based retrospective study.
Combined structural and functional patterns discriminating upper limb motor disability in multiple sclerosis using multivariate approaches.
SigmaPharm Laboratories Products
No association between genetic polymorphism at codon 129 of the prion protein gene and primary progressive multiple sclerosis.
Risks of immune system treatments.
Site-Specific PEGylation Enhances the Pharmacokinetic Properties and Antitumor Activity of Interferon Beta-1b.
ABC-transporter gene-polymorphisms are potential pharmacogenetic markers for mitoxantrone response in multiple sclerosis.
Down Syndrome Developmental Brain Transcriptome Reveals Defective Oligodendrocyte Differentiation and Myelination.
Nanoparticle transport across the blood brain barrier.
Functional Characterization of DNA Methylation in the Oligodendrocyte Lineage.
The influence of disease duration, clinical course, and immunosuppressive therapy on the synthesis of intrathecal oligoclonal IgG bands in multiple sclerosis.
Influence of Previous Failed Antispasticity Therapy on the Efficacy and Tolerability of THC:CBD Oromucosal Spray for Multiple Sclerosis Spasticity.
LKB1/STRAD promotes axon initiation during neuronal polarization.
Summary of comprehensive systematic review: Rehabilitation in multiple sclerosis: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology.
Newly onset sinus bradycardia in the context of multiple sclerosis relapse.
Rituximab Efficiently Depletes Increased CD20-Expressing T Cells in Multiple Sclerosis Patients.
Extensive bilateral lower extremity deep venous thrombosis in a patient on dimethyl fumarate.
Pages
« first
‹ previous
…
52
53
54
55
56
57
58
59
60
…
next ›
last »